reduction in
mean WOMAC pain
subscale scores from
baseline at 6 months
‒18.4 ± 1.5 mm
(mean ± SE)
reduction in mean
global VAS knee pain
from baseline
‒ 26.7 mm
(range ‒30.0 to ‒23.4)
met the minimum OARSI/OMERACT responder rate for improvement in pain and function
met the MCII Pain responder rate, with 56% meeting the MCII Function responder rate
MCII, minimum clinically important improvement; OARSI, Osteoarthritis Research Society International; OMERACT, outcome measures in rheumatology; VAS, visual analogue scale; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index